Protocolo diagnóstico y terapéutico de la tromboembolia de pulmón
- Jiménez Castro, David
- Kopecna, D.
- de Miguel Díez, Javier
- Sueiro Bendito, Antonio
ISSN: 0304-5412
Año de publicación: 2014
Título del ejemplar: Enfermedades respiratorias (VI): Enfermedades vasculares pulmonares y pleurales
Serie: 11
Número: 68
Páginas: 4093-4096
Tipo: Artículo
Otras publicaciones en: Medicine: Programa de Formación Médica Continuada Acreditado
Objetivos de desarrollo sostenible
Resumen
Pulmonary thromboembolism (PTE) is the third cause of cardiovascular death after acute myocardial infarction and ictus. In patients with suspected pulmonary embolism, the adherence to commonly accepted diagnostic guidelines improves the prognostic. The treatment as well as the place of treatment depends on initial severity. If no contraindications exist, anticoagulant therapy must be prescribed during at least 3 months. Undefined treatment must be taking into account in patients with risk of recurrence and bleeding as well the patient preferences.
Referencias bibliográficas
- Jaff MR, Archer SL, Cushman M, Goldenberg N, Goldhaber SZ, Jenkins S. Management of Massive and Submassive Pulmonary Embolism, Iliofemoral Deep Vein Thrombosis, and Chronic Thromboembolic Pulmonary Hypertension: A Scientific Statement From the American Heart Association. Circulation. 2011;123:1788-830.
- Kearon C, Akl EA, Comerota AJ, Prandoni P, Bounameaux H, Goldhaber SZ. Antithrombotic Therapy for VTE Disease Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians. Evidence-Based Clinical Practice Guidelines. Chest. 2012; 141:419S-494S.
- Konstantinides S, Torbicki A, Agnelli G, Danchin N, Fitzmaurice D, Galiè N. 2014 ESC Guidelines on the diagnosis and management of acute pulmonary embolism: The Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology (ESC) Endorsed by the European Respiratory Society (ERS). Eur Heart J. En prensa 2014.